ArticleJournal of cellular and molecular medicine2020

Bcl-xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms.

Jessica Petiti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.